Li Ren
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)
- Cited by
- Cancer ResearchOncologyHepatology
- Journals
- Nature CommunicationsBloodPLoS ONE
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Li Ren
32 papers receiving 379 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 175
- Cancer Research 96
- Oncology 94
- Cell Biology 55
- Epidemiology 38
Countries citing papers authored by Li Ren
This map shows the geographic impact of Li Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ren more than expected).
Fields of papers citing papers by Li Ren
This network shows the impact of papers produced by Li Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ren. The network helps show where Li Ren may publish in the future.
Co-authorship network of co-authors of Li Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Li Ren. A scholar is included among the top collaborators of Li Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Ren. Li Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 28 | |
| 11 | 7 | |
| 12 | 28 | |
| 13 | 60 | |
| 14 | 6 | |
| 15 | 5 | |
| 16 | 20 | |
| 17 | 11 | |
| 18 | 7 | |
| 19 | 7 | |
| 20 | 77 |
About Li Ren
Li Ren is a scholar working on Hepatology, Cancer Research and Oncology, having authored 36 papers that have together received 385 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (96 citations), Oncology (94 citations) and Hepatology (27 citations). Li Ren has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Duo Zuo, Yanjie He, Liu R, Guoguang Ying, Ting Deng, Lyu Zhou, Yi Ba, Jingwen Chen, Wenna Jiang and Wentao Tang. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.